Sector ratings United Therapeutics Corporation

Equities

Real-time Estimate Cboe BZX Other stock markets 10:46:02 2026-02-18 EST			5-day change	1st Jan Change
479.26 ^USD	-0.66%		+0.75%	-1.61%

01-26	United Therapeutics Corporation Announces Positive Results from Phase 1 Study of MiroliverELAP® in Patients with Acute Liver Failure	CI
01-26	United Therapeutics Says Its Experimental Liver Assist Device Met Primary Goal in Phase 1 Study	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	ESG MSCI
UNITED THERAPEUTICS CORPORATION	20.77B	A
ELI LILLY AND COMPANY	926B	A
JOHNSON & JOHNSON	586B	BBB
ABBVIE INC.	412B	AA
ROCHE HOLDING AG	382B	AA
ASTRAZENECA PLC	326B	A
NOVARTIS AG	317B	AAA
MERCK & CO., INC.	302B	A
NOVO NORDISK A/S	218B	A
AMGEN INC.	201B	A
GILEAD SCIENCES, INC.	193B	AAA
PFIZER INC.	156B	BBB
VERTEX PHARMACEUTICALS INCORPORATED	121B	AA
BRISTOL-MYERS SQUIBB COMPANY	123B	A
GSK PLC	122B	AA
SANOFI	112B	A
CHUGAI PHARMACEUTICAL CO., LTD.	98.24B	AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	57.14B	AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	56B	AA
BAYER AG	57.3B	AA
Average	239.22B	AA
Weighted average by Cap.		AA